Who owns DRUGS MADE IN AMER ACQ II CO?
- Ticker: DMIIU
- CUSIP Number: g2851k120
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acq Ii with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acq Ii stock
Who bought or sold DRUGS MADE IN AMER ACQ II CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 2.7M | $27M | 0% | Dec 2025 |
|
| LMR Partners | 2.0M | $20M | 0% | Mar 2026 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 2.0M | $20M | 0% | Dec 2025 |
|
| Heights Capital Management | 519k | $5.2M | 0% | Dec 2025 |
|
| Westchester Capital Management | 503k | $5.0M | 0% | Mar 2026 |
|
| TIG Advisors | 500k | $5.0M | 0% | Mar 2026 |
|
| Verition Fund Management | 250k | $2.5M | 0% | Mar 2026 |
|
| BlueCrest Capital Management | 250k | $2.5M | 0% | Mar 2026 |
|
| Kepos Capital | 210k | $2.1M | 100% | Mar 2026 |
|
| Clear Street Group | 167k | $1.7M | 100% | Mar 2026 |
|
| Hrt Financial | 100k | $1.0M | -27% | Mar 2026 |
|
| Walleye Trading Advisors | 100k | $1.0M | 0% | Mar 2026 |
|
| Readystate Asset Management | 100k | $1.0M | 0% | Mar 2026 |
|
| Rangeley Capital | 56k | $327k | 71% | Mar 2026 |
|
| Robinson Capital Management | 15k | $151k | -40% | Mar 2026 |
|
| UBS Group | 1.8k | $18k | -98% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acq Ii?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vivaldi Asset Management | Sep 2025 | 1.9M | $19M |
| HGC Investment Management | Sep 2025 | 1.2M | $12M |
| Millennium Management | Dec 2025 | 500k | $5.0M |
| K2 Principal Fund | Sep 2025 | 427k | $4.2M |
| Rivernorth Capital Management | Dec 2025 | 400k | $4.0M |
| Toronto-Dominion Bank | Sep 2025 | 350k | $3.5M |
| Steadfast Capital Management | Dec 2025 | 300k | $3.0M |
| Lighthouse Investment Partners | Sep 2025 | 300k | $3.0M |
| Gabelli Securities | Dec 2025 | 180k | $1.8M |
| Gabelli Funds | Dec 2025 | 161k | $1.6M |
| Jpmorgan Chase & Co | Sep 2025 | 130k | $1.3M |
| Schonfeld Strategic Advisors | Dec 2025 | 114k | $1.1M |
| Centiva Capital | Dec 2025 | 100k | $1.0M |
| Governors Lane | Sep 2025 | 100k | $994k |
| Parallax Volatility Advisers | Dec 2025 | 89k | $892k |
| Royal Bank of Canada | Sep 2025 | 75k | $746k |
| Springbok Capital Management | Dec 2025 | 50k | $501k |
| PenderFund Capital Management | Dec 2025 | 50k | $497k |
| Quarry | Sep 2025 | 40k | $398k |
| Qube Research & Technologies | Sep 2025 | 34k | $336k |
| Susquehanna International | Dec 2025 | 25k | $251k |
| Boothbay Fund Management | Dec 2025 | 25k | $250k |